AbbVie Inc.
A research-based biopharmaceutical company developing and manufacturing medicines.
ABBV | US
Overview
Corporate Details
- ISIN(s):
- US00287Y1091
- LEI:
- Country:
- United States of America
- Address:
- 1 NORTH WAUKEGAN ROAD, 60064 NORTH CHICAGO
- Website:
- https://www.abbvie.com/
- Sector:
- Manufacturing
Description
AbbVie Inc. is a global, research-based biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative medicines and therapeutic solutions. The company's mission is to address complex health issues and make a significant impact on patients' lives by combining advanced science with deep expertise. AbbVie develops treatments across various therapeutic areas, aiming to solve serious health challenges. In addition to its proprietary product pipeline, the company also offers contract manufacturing services for both small molecules and biologics, supporting other pharmaceutical partners in their development and production needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-05-06 08:00 |
AbbVie Inc. - Rule 2.10 Announcement
|
English | 11.9 KB | ||
| 2020-04-29 12:00 |
AbbVie Inc. - Rule 2.10 Announcement
|
English | 3.0 KB | ||
| 2020-04-15 12:00 |
AbbVie Inc. - Rule 2.10 Announcement
|
English | 3.0 KB | ||
| 2017-07-31 08:00 |
AbbVie Inc. annonce sa radiation d'Euronext Paris
|
French | 5.1 KB | ||
| 2017-07-31 08:00 |
AbbVie Inc. Announces Delisting from Euronext Paris
|
English | 4.6 KB | ||
| 2017-04-27 14:49 |
AbbVie Reports First-Quarter 2017 Financial Results
|
English | 23.2 KB | ||
| 2017-03-21 00:45 |
AbbVie Files Definitive Proxy Statement on Schedule 14A
|
English | 1.7 KB | ||
| 2017-03-21 00:45 |
AbbVie Files Definitive Proxy Statement on Schedule 14A
|
English | 2.6 MB | ||
| 2017-02-21 08:00 |
AbbVie Files Form 10-K
|
English | 1.7 KB | ||
| 2017-02-21 08:00 |
AbbVie Files Form 10-K
|
English | 4.2 MB | ||
| 2017-02-17 14:00 |
AbbVie Announces $5 Billion Increase to Stock Repurchase Program
|
English | 1.7 KB | ||
| 2017-02-17 07:14 |
AbbVie Declares Quarterly Dividend
|
English | 1.8 KB | ||
| 2016-11-18 13:41 |
AbbVie Inc. Prospectus Supplement
|
English | 710 bytes | ||
| 2016-11-18 09:49 |
AbbVie Inc. Form 8-A
|
English | 167.8 KB | ||
| 2016-11-18 09:49 |
AbbVie Inc. Form 8-A
|
English | 6.4 KB |
Automate Your Workflow. Get a real-time feed of all AbbVie Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AbbVie Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AbbVie Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
